Target intelligence / Profile preview

Tetratricopeptide repeat domain 13 (TTC13)

Target
TTC13
Molecular classification
Other (Scaffold/adaptor protein), Tetratricopeptide repeat (TPR)-containing protein
01

Overview

Tetratricopeptide repeat domain 13 (TTC13) is a protein-coding gene in humans, encoding a protein with multiple tetratricopeptide repeat (TPR) motifs[1][4][8]. These repeats are short structural motifs involved in protein–protein interactions and often participate in the assembly of multiprotein complexes and scaffolding functions[3][8]. While the broader TTC (tetratricopeptide repeat-containing) family mediates important cell functions such as protein transport, complex formation, and, in some cases, cilia formation, direct biological functions and molecular partners of TTC13 remain poorly characterized[2]. No confirmed enzymatic activities, receptor activities, or roles in central cellular signaling pathways have been assigned to TTC13. The gene is occasionally associated in genetics resources with disorders such as Wilson-Turner syndrome, but its mechanistic involvement is unproven. There are no drugs or clinical biomarkers known for this protein. Tetratricopeptide repeat domain 13 (TTC13) is a human scaffold/adaptor protein with TPR motifs, facilitating protein–protein interactions. It is non-enzymatic, non-receptor, and not described as a therapeutic target, with limited disease association or functional data[1][4][8].

Other names
Tetratricopeptide repeat protein 13TTC13PSEC0076TPR repeat protein 13FLJ22584BC017545Epididymis secretory sperm binding protein (low-frequency)
02

Biological functions

Protein complex assembly/formation (Putative; based on TPR motif properties)May have roles in scaffolding or protein–protein interactionsAssociated with cilia-related processes (inferred from family studies, not direct evidence for TTC13)
03

Disease associations

Other (No conclusive role in disease established; minor literature mentions possible association with Wilson-Turner syndrome, but mechanism is uncharacterized)Possible involvement in cancer progression (one report cites expression and STAT3 activation loop in renal cell carcinoma, but functional evidence is limited)

Beyond the preview

Go deeper on Tetratricopeptide repeat domain 13 (TTC13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetratricopeptide repeat domain 13 (TTC13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call